Clinical Trials Directory

Trials / Completed

CompletedNCT04891926

Hormonal Influences on Diuresis

Influence of Hormonale Changes on Diuresis and LUTS in the Gynaecological Population

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
Female
Age
40 Years
Healthy volunteers
Accepted

Summary

The aim of this study was to observe the effect of hormonal treatment (oral or transdermal substitution therapy) on diuresis (salt and water diuresis) and lower urinary tract symptoms (LUTS) in postmenopausal women

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTICIQ FLUTS QuestionairesQuestionnaire observing the impact on voiding disfunctions
DIAGNOSTIC_TESTFrequency Volume ChartFrequency Volume Chart measures the voided volumes and fluid intake during 3 days in order to observe patients bladder capacity, total and nighttime voided volume and voiding frequency
DIAGNOSTIC_TESTRenal Function ProfileThe RFP is a 24-hour urine analysis in which urine samples are collected at fixed time points every 3 hours, starting 3 hours after the first morning void. This RFP was collected on a separated day to the FVC. Daytime samples were taken between 10:00-11:30 (U1), 13:00-15:30 (U2), 16:00-17:30 (U3), 19:00-20:30 (U4), and 22:00-23:30 (U5). The night-time samples were taken between 1:00-2:30 (U6), 4:00-5:30 (U7) and 7:00-8:30 (U8), and the volume of each interim void, was noted to calculate the 24h, daytime and night-time urine volume and diuresis rate. On each of this 8 samples, creatinine, osmolality, sodium and urea concentration were analysed. Subsequently, the renal clearance of creatinine, solutes, sodium and potassium (Usubst x Uflow / Psubst) and FWC (urine flow - solute clearance) were calculated.
DIAGNOSTIC_TESTBlood AnalysisBlood analysis in order to observ postmenopausal state, osmolalitity and sodium.

Timeline

Start date
2015-05-01
Primary completion
2018-09-30
Completion
2018-09-30
First posted
2021-05-19
Last updated
2021-05-19

Source: ClinicalTrials.gov record NCT04891926. Inclusion in this directory is not an endorsement.